OCD
Conditions
Keywords
treatment, psychotherapy, pharmacotherapy
Brief summary
The purpose of this study is to provide participants diagnosed with obsessive compulsive disorder (OCD) and completed one of the active study protocols at the Rodriguez Lab, with open/aftercare treatment.
Detailed description
After completing one of the active clinical studies participants have the option to enroll in this protocol that offers open treatment. The goal is to compare two forms of current standard treatments, psychotherapy vs pharmacotherapy.
Interventions
BEHAVIORALPsychotherapy
Evidenced based psychotherapy by a trained psychologist
OTHERPharmacotherapy
Pharmacotherapy by a psychiatrist
Sponsors
Stanford University
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Participants will choose to enter the psychotherapy or pharmacotherapy arm.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Ability to speak and understand English 2. Capacity to consent (e.g. as determined by assessing the patient's understanding of the risks, benefits, and procedures of the study) 3. Completed an active study protocol at the Rodriguez Lab at Stanford University
Exclusion criteria
1. Children younger than 18 2. Active suicidality
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS) | Up to 14 weeks | Improvement in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS. |
Countries
United States
Outcome results
None listed